ARCHIVES

It is The First FDA Withdrawl Of An Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

Abigail Alliance says statisticians usurped control of oncology. Milken’s optimism fuels the movement.

August 5, 2005

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985